CONCOURSE FINANCIAL GROUP SECURITIES, INC. - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 39 filers reported holding PLURISTEM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
CONCOURSE FINANCIAL GROUP SECURITIES, INC. ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$000.00%
Q1 2022$0
-100.0%
0
-100.0%
0.00%
Q4 2021$3,000
-40.0%
1,7770.0%0.00%
Q3 2021$5,000
-28.6%
1,7770.0%0.00%
Q2 2021$7,000
-12.5%
1,7770.0%0.00%
-100.0%
Q1 2021$8,000
-38.5%
1,7770.0%0.00%0.0%
Q4 2020$13,0001,7770.00%
Q3 2020$000.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$000.00%
Q3 2019$000.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 732,135$1,940,0000.83%
Green Alpha Advisors, LLC 61,759$164,0000.11%
Values First Advisors, Inc. 49,179$130,0000.08%
GSA CAPITAL PARTNERS LLP 257,684$683,0000.07%
SHELTON CAPITAL MANAGEMENT 240,000$636,0000.02%
Walleye Capital LLC 154,997$411,0000.01%
PDT Partners, LLC 59,400$157,0000.01%
Archford Capital Strategies, LLC 13,091$35,0000.01%
Susquehanna International Group Ltd. 13,164$35,0000.01%
MEITAV INVESTMENT HOUSE LTD 167,593$444,0000.01%
View complete list of PLURISTEM THERAPEUTICS INC shareholders